Hemodynamic Effects of Alpha Blockers in Patients With Spinal Anesthesia
The Effect of Spinal Anaesthesia on Haemodynamic Parameters in Patients Receiving Alpha Blockers
1 other identifier
observational
80
1 country
1
Brief Summary
There is frequent use of alpha blockers in elderly patients with urological disorders. Various side effects are encountered due to the use of alpha blockers in the elderly age group. Especially hypotension is one of the common side effects. In addition, urological surgery is frequently performed in this age group. Spinal anesthesia is the most preferred anesthesia method in urological surgery. Spinal anesthesia may cause significant vasodilatation and thus hemodynamic changes such as hypotension by causing sympathetic nerve blockade. It is predicted that spinal anesthesia may increase these effects especially in individuals using α-1 adrenergic blockers. In the literature, serious hypotension has been encountered in individuals using alpha blockers under general anesthesia. The aim of this study was to compare the intraoperative hemodynamic changes in patients undergoing elective urologic surgery under spinal anesthesia between α-1 adrenergic blocker users (Group 1) and non-users(Group 2). Patients were divided into two groups according to drug use: Group 1: α-1 adrenergic blocker users (alfuzosin, doxazosin, terazosin,silodosin, tamsulosin), Group 2: No α-1 adrenergic blockers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2025
CompletedFirst Posted
Study publicly available on registry
May 31, 2025
CompletedStudy Start
First participant enrolled
August 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2025
CompletedAugust 20, 2025
July 1, 2025
1 month
May 22, 2025
August 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Preop,15 minute,30minute mean arteriyal pressure
Hypotension MBP \< 50 mmHg
During procedure (From the beginning to the end of anesthesia)
Secondary Outcomes (1)
Preoperative, 15th and 30th minute heart rate
During procedure (From the beginning to the end of anesthesia)
Study Arms (2)
Group 1: α-1 adrenergic blocker users
Group 2: No α-1 adrenergic blockers.
Eligibility Criteria
Patients scheduled for elective urologic surgery under spinal anesthesia
You may qualify if:
- Patients with American Society of Anesthesiologists (ASA) physical status classification I,II or III over 18 years of age scheduled for elective urologic surgery under spinal anesthesia
You may not qualify if:
- Patients not undergoing spinal anesthesia, non-alpha-blocker vasoactive drug users, patients with cardiac disease, medical/surgical history of brain or spinal cord, neurological or psychiatric disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
İzmir City Hospital
Izmir, Bayraklı, 35000, Turkey (Türkiye)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD,Specialist
Study Record Dates
First Submitted
May 22, 2025
First Posted
May 31, 2025
Study Start
August 30, 2025
Primary Completion
September 30, 2025
Study Completion
October 30, 2025
Last Updated
August 20, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share